Advertisement
Screener

TELEFLEX INCORPORATED (TFX) Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax

TELEFLEX INCORPORATED Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax

TELEFLEX INCORPORATED (TFX) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax of $631.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.

Discontinued › Expense Statement › Income Tax

us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax · last filed 2018-02-22

  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2012-07-01 was -$334.00K.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2012-04-01 was $321.00K, a 38.96% increase year-over-year.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2011-06-26 was -$511.00K.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for the quarter ending 2011-03-27 was $231.00K.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2017 was $631.00K.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2016 was -$1.36M.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2015 was -$379.00K, a 441.44% decline from fiscal 2014.
  • TELEFLEX INCORPORATED other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, tax for fiscal 2014 was $111.00K, a 58.11% decline from fiscal 2013.
Period endOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 3 monthOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 6 monthOther Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax 12 month
2017-12-31$631.00K
10-K · filed 2018-02-22
2016-12-31-$1.36M
10-K · filed 2018-02-22
2015-12-31-$379.00K
10-K · filed 2018-02-22
2014-12-31$111.00K
10-K · filed 2017-02-23
2013-12-31$265.00K
10-K · filed 2016-02-25
2012-12-31$102.00K
10-K · filed 2015-02-20
2012-07-01-$334.00K
10-Q · filed 2012-07-31
-$13.00K
10-Q · filed 2012-07-31
2012-04-01$321.00K
10-Q · filed 2012-05-01
2011-06-26-$511.00K
10-Q · filed 2012-07-31
-$280.00K
10-Q · filed 2012-07-31
2011-03-27$231.00K
10-Q · filed 2012-05-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55